Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：35
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [21] Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
    Holman, Rury R.
    Sourij, Harald
    Califf, Robert M.
    LANCET, 2014, 383 (9933): : 2008 - 2017
  • [22] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Bianchi, Cristina
    Daniele, Giuseppe
    Dardano, Angela
    Miccoli, Roberto
    Del Prato, Stefano
    DRUGS, 2017, 77 (03) : 247 - 264
  • [23] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Cristina Bianchi
    Giuseppe Daniele
    Angela Dardano
    Roberto Miccoli
    Stefano Del Prato
    Drugs, 2017, 77 : 247 - 264
  • [24] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [25] Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective
    Thompson, Peter L.
    Davis, Timothy M. E.
    CLINICAL THERAPEUTICS, 2017, 39 (05) : 1012 - 1025
  • [26] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
    Tomlinson, Brian
    Chan, Paul
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (04) : 175 - 179
  • [27] Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
    Hafiz Muhammad Adnan Tariq
    Nayyab Younas Khan
    Haseeb Manzoor
    Masood Ur Rehman Kayani
    Discover Medicine, 2 (1):
  • [28] Use of oral glucose-lowering drugs in a healthcare area
    Garcia de Paredes Esteban, Juan Carlos
    Mora Herrera, Cristina
    REVISTA ESPANOLA DE SALUD PUBLICA, 2021, 95
  • [29] Contemporary management of type 2 diabetes: blood glucose-lowering therapies and glycaemic targets
    Davis, Timothy M. E.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 189 (05) : 246 - 248
  • [30] Personalized glucose-lowering effect of chiglitazar in type 2 diabetes
    Huang, Qi
    Zou, Xiantong
    Chen, Yingli
    Gao, Leili
    Cai, Xiaoling
    Zhou, Lingli
    Gao, Fei
    Zhou, Jian
    Jia, Weiping
    Ji, Linong
    ISCIENCE, 2023, 26 (11)
12345